Matches in Nanopublications for { <http://rdf.disgenet.org/nanopublications.trig#NP650862.RAYWNnNbmAJbheAhtP8VvyYOt2aipVMUpzcS_LpKfLeGI130_assertion> ?p ?o ?g. }
Showing items 1 to 6 of
6
with 100 items per page.
- NP650862.RAYWNnNbmAJbheAhtP8VvyYOt2aipVMUpzcS_LpKfLeGI130_assertion type Assertion NP650862.RAYWNnNbmAJbheAhtP8VvyYOt2aipVMUpzcS_LpKfLeGI130_head.
- NP650862.RAYWNnNbmAJbheAhtP8VvyYOt2aipVMUpzcS_LpKfLeGI130_assertion description "[A study of complex I (NADH:ubiquinone oxidoreductase) activity in Parkinson's disease (PD) brain has identified loss of activity only in substantia nigra although loss of activity of this enzyme has been identified in a number of non-brain tissues.]. Sentence from MEDLINE/PubMed, a database of the U.S. National Library of Medicine." NP650862.RAYWNnNbmAJbheAhtP8VvyYOt2aipVMUpzcS_LpKfLeGI130_provenance.
- NP650862.RAYWNnNbmAJbheAhtP8VvyYOt2aipVMUpzcS_LpKfLeGI130_assertion evidence source_evidence_literature NP650862.RAYWNnNbmAJbheAhtP8VvyYOt2aipVMUpzcS_LpKfLeGI130_provenance.
- NP650862.RAYWNnNbmAJbheAhtP8VvyYOt2aipVMUpzcS_LpKfLeGI130_assertion SIO_000772 18061150 NP650862.RAYWNnNbmAJbheAhtP8VvyYOt2aipVMUpzcS_LpKfLeGI130_provenance.
- NP650862.RAYWNnNbmAJbheAhtP8VvyYOt2aipVMUpzcS_LpKfLeGI130_assertion wasDerivedFrom befree-20140225 NP650862.RAYWNnNbmAJbheAhtP8VvyYOt2aipVMUpzcS_LpKfLeGI130_provenance.
- NP650862.RAYWNnNbmAJbheAhtP8VvyYOt2aipVMUpzcS_LpKfLeGI130_assertion wasGeneratedBy ECO_0000203 NP650862.RAYWNnNbmAJbheAhtP8VvyYOt2aipVMUpzcS_LpKfLeGI130_provenance.